Sinovac Biotech Ltd., a leading provider of vaccines in China, today announcedthat the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot releaseprocess of China's National Institute for the Control of Pharmaceutical andBiological Products and obtained the Certificate for the Release of BiologicalProducts, which means the released vaccines are ready for delivery. The released vaccine will be supplied to the Beijing CDC and China'scentral government. Sinovac has previously announced an order of five milliondoses with the minimum purchase quantity of two million doses from the BeijingCDC and 3.3 million doses from the central government, all of which is to bedelivered by the end of September. Mr. Weidong Yin, Chairman, President and CEO, commented, "We are proud tobe at the forefront of the fight against the H1N1 virus. With these shipments,we can, along with the government and our fellow companies, begin the fight inearnest to control the spread of H1N1."